PRKAA1 and osteosarcoma: We next incubated human osteosarcoma (U2OS) cells with the ADaM site activator MK-8722, (which was added to increase the signals obtained with phosphospecific antibodies against AMPK targets), and various concentrations of BAY-3827 or the negative control compound, BAY-974.